These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer. Deligdisch L; Kalir T; Cohen CJ; de Latour M; Le Bouedec G; Penault-Llorca F Gynecol Oncol; 2000 Aug; 78(2):181-6. PubMed ID: 10926800 [TBL] [Abstract][Full Text] [Related]
3. [Precancerous lesion of the endometrium and endometrial morphology in patients with tamoxifen therapy]. Schmidt D; Horn LC Zentralbl Gynakol; 2002 Jan; 124(1):3-9. PubMed ID: 11873307 [TBL] [Abstract][Full Text] [Related]
4. [Role of steroid hormones and related biological substances in the etiology of endometrial carcinomas]. Lang-Avérous G; Rupp K; Wehner H; Dallenbach-Hellweg G Verh Dtsch Ges Pathol; 1991; 75():366-9. PubMed ID: 1724843 [TBL] [Abstract][Full Text] [Related]
5. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer. Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP Menopause; 2009; 16(2):293-300. PubMed ID: 19034048 [TBL] [Abstract][Full Text] [Related]
6. Histopathology of functional and neoplastic changes in cervix and endometrium. Dallenbach-Hellweg G Verh Dtsch Ges Pathol; 1997; 81():240-4. PubMed ID: 9474876 [TBL] [Abstract][Full Text] [Related]
7. The endometrium in breast cancer patients on tamoxifen. Dallenbach-Hellweg G; Schmidt D; Hellberg P; Bourne T; Kreuzwieser E; Dören M; Rydh W; Rudenstam G; Granberg S Arch Gynecol Obstet; 2000 Apr; 263(4):170-7. PubMed ID: 10834325 [TBL] [Abstract][Full Text] [Related]
8. [Pathology of the endometrium in breast cancer patients treated with tamoxifen (nolvadex)]. Ivanova V; Karaivanov M; Marinov E; Gorchev G; Velkova A; Khristova P Akush Ginekol (Sofiia); 2003; 42(5):3-8. PubMed ID: 14682005 [TBL] [Abstract][Full Text] [Related]
9. Steroid receptor expression in endometria from women treated with tamoxifen. Kommoss F; Karck U; Prömpeler H; Pfisterer J; Kirkpatrick CJ Gynecol Oncol; 1998 Aug; 70(2):188-91. PubMed ID: 9740688 [TBL] [Abstract][Full Text] [Related]
10. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy]. Hauth E; Libera H; Kimmig R; Forsting M Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840 [TBL] [Abstract][Full Text] [Related]
11. [Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen]. Semiglazov VF; Maksimov SIa; Bulgatova EA; Meshkova IE; Chepik OF; Berstein LM Vopr Onkol; 2003; 49(2):198-204. PubMed ID: 12785205 [TBL] [Abstract][Full Text] [Related]
12. Maturation of vaginal and endometrial epithelium in postmenopausal breast cancer patients receiving long-term tamoxifen. Lahti E; Vuopala S; Kauppila A; Blanco G; Ruokonen A; Laatikainen T Gynecol Oncol; 1994 Dec; 55(3 Pt 1):410-4. PubMed ID: 7835781 [TBL] [Abstract][Full Text] [Related]
13. Genomic changes in endometrial polyps associated with tamoxifen show no evidence for its action as an external carcinogen. Dal Cin P; Timmerman D; Van den Berghe I; Wanschura S; Kazmierczak B; Vergote I; Deprest J; Neven P; Moerman P; Bullerdiek J; Van den Berghe H Cancer Res; 1998 Jun; 58(11):2278-81. PubMed ID: 9622058 [TBL] [Abstract][Full Text] [Related]
14. Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen. Lahti E; Blanco G; Kauppila A; Apaja-Sarkkinen M; Taskinen PJ; Laatikainen T Obstet Gynecol; 1993 May; 81(5 ( Pt 1)):660-4. PubMed ID: 8469450 [TBL] [Abstract][Full Text] [Related]
15. Hysteroscopic dynamic assessment of the endometrium in patients treated with long-term tamoxifen. Pérez-Medina T; Salazar FJ; San-Frutos L; Ríos M; Jiménez JS; Troyano J; Cayuela E; Iglesias E J Minim Invasive Gynecol; 2011; 18(3):349-54. PubMed ID: 21411378 [TBL] [Abstract][Full Text] [Related]
16. [Histological analysis of endometrial polyps in breast cancer patients treated with tamoxifen (nolvadex)]. Ivanova V; Karaivanov M; Raĭcheva S; Marinov E; Gorchev G Akush Ginekol (Sofiia); 2004; 43(2):33-6. PubMed ID: 15185527 [TBL] [Abstract][Full Text] [Related]
17. Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings. Hann LE; Giess CS; Bach AM; Tao Y; Baum HJ; Barakat RR AJR Am J Roentgenol; 1997 Mar; 168(3):657-61. PubMed ID: 9057510 [TBL] [Abstract][Full Text] [Related]
18. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients. Cheng WF; Lin HH; Torng PL; Huang SC Gynecol Oncol; 1997 Aug; 66(2):233-7. PubMed ID: 9264568 [TBL] [Abstract][Full Text] [Related]
19. Histopathology of endometrial hyperplasia and endometrial carcinoma: an update. Horn LC; Meinel A; Handzel R; Einenkel J Ann Diagn Pathol; 2007 Aug; 11(4):297-311. PubMed ID: 17630117 [TBL] [Abstract][Full Text] [Related]
20. Indication of hysteroscopy in tamoxifen treated breast cancer patients. Taponeco F; Curcio C; Fasciani A; Giuntini A; Artini PG; Fornaciari G; Petraglia F; Genazzani AR J Exp Clin Cancer Res; 2002 Mar; 21(1):37-43. PubMed ID: 12071527 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]